Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

April 30, 2011

Conditions

Healthy

Interventions

DRUG

Warfarin

Warfarin 5 mg once daily

DRUG

Warfarin 5mg + Rosuvastatin 40 mg once daily (QD)

DRUG

Warfarin 5 mg + Pitavastatin 4mg once daily (QD)

Warfarin 5 mg + Pitavastatin 4mg

Trial Locations (1)

Austin